{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-269488","form_type":"8-K","ticker":"TKNO","cik":"0001850902","company_name":"Alpha Teknova, Inc.","filed_at":"2025-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.809654+00:00","generated_at":"2026-05-16T23:59:39.284377+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"confidence":"high","headline":"Teknova Q3 revenue $10.5M (+9% YoY); net loss narrows to $4.3M; reaffirms FY2025 guidance","bullets":["Revenue $10.5M, up 9% from Q3 2024; Lab Essentials $8.3M (+16%), Clinical Solutions $1.7M (-13%).","Gross margin 30.7% vs 0.9% (Q3 2024); prior year included $2.8M non-recurring inventory charges.","Net loss $4.3M ($0.08/share) vs $7.6M ($0.15/share) a year ago; Adjusted EBITDA -$1.6M vs -$5.0M.","Free Cash Outflow $2.4M, flat YoY. Cash & short-term investments $22.1M; borrowings $13.2M.","Reaffirms FY2025 revenue guidance $39-42M and Free Cash Outflow <$12M."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-269488","json":"https://secwatch.observer/filing/0001193125-25-269488.json","markdown":"https://secwatch.observer/filing/0001193125-25-269488.md","text":"https://secwatch.observer/filing/0001193125-25-269488.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850902/000119312525269488/0001193125-25-269488-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850902/000119312525269488/tkno-20251106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T23:59:39.284377+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}